Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00689117 · ClinicalTrials.gov registry record · Phase 3
A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel
A Phase 3 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,649
- Enrollment target
NCT00689117 is a Phase 3 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 1,649 participants.
The verdict
NCT00689117, a Phase 3 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,649 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.
Interventions
- DRUG Vehicle Gel
- DRUG CT Gel
- DRUG Clindamycin Gel (clindamycin )
- DRUG Tretinoin Gel (tretinoin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,649 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00689117
The ClinicalTrials.gov registry entry for NCT00689117 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,649 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vehicle Gel is the first listed.
NCT00689117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00689117 about?
NCT00689117 is a clinical study titled "A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel". The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.
What is the current status of trial NCT00689117?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,649 participants. The study started on 2008-04. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00689117?
The interventions under investigation include: Vehicle Gel (DRUG), CT Gel (DRUG), Clindamycin Gel (clindamycin ) (DRUG), Tretinoin Gel (tretinoin) (DRUG).
Who is sponsoring clinical trial NCT00689117?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.